Related Experiment Video
Updated: Sep 13, 2026

Rescue and Characterization of Recombinant Virus from a New World Zika Virus Infectious Clone
Published on: June 7, 2017
Reinfection of COVID-19 in Pakistan: A First Case Report
Muhammad Hanif1, Muhammad Adnan Haider2, Mukarram Jamat Ali3
1Internal Medicine, Khyber Medical College, Peshawar, PAK.
Insights
This case report details the first documented instance of COVID-19 reinfection in Pakistan. A patient recovered from SARS-CoV-2 infection but was reinfected within two months, raising questions about immune protection duration.
Area of Science:
- Immunology
- Infectious Diseases
- Virology
Background:
- Coronavirus disease 2019 (COVID-19), caused by SARS-CoV-2, presents a significant global health challenge with many unresolved aspects.
- Antibody responses to SARS-CoV-2 infection vary, with some patients exhibiting rapid antibody waning, impacting long-term immunity.
- The duration and adequacy of protective immune responses following COVID-19 infection remain largely undetermined.
Observation:
- A case of COVID-19 reinfection was documented in Pakistan, occurring within two months of initial recovery.
- The initial SARS-CoV-2 infection was severe and confirmed by negative nasopharyngeal swabs post-recovery.
- The patient experienced a second SARS-CoV-2 infection despite a prior confirmed infection and recovery.
Findings:
- This report presents the first confirmed case of COVID-19 reinfection in Pakistan.
- The reinfection occurred less than two months after complete recovery from the primary SARS-CoV-2 infection.
- Sequential negative nasopharyngeal swabs confirmed the resolution of the first infection before the second occurred.
Implications:
- This case highlights the potential for rapid SARS-CoV-2 reinfection, even after apparent recovery.
- It raises critical questions about the durability of natural immunity against COVID-19.
- Further research is needed to understand the factors influencing immune protection duration and reinfection risk.
Abstract:
Since its spread across the world, coronavirus disease 2019 (COVID-19) has posed a severe public health threat, and many unanswered questions about COVID-19 remain. Antibodies have been detected a few days after the onset of infection, and in some patients, these antibodies wane quickly. To date, it is unknown whether all infected patients induce an adequate protective immune response or how long this effect remains. Here, a first case report of COVID-19 reinfection in Pakistan is reported within two months of complete recovery from the first severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2) infection - confirmed with two sequential negative nasopharyngeal swabs.
Related Concept Videos
Viral Recombination
Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Poliomyelitis
Toxoplasmosis

